GS1 Pharmaceutical Image Implementation Guideline
The purpose of this document is to provide a method of image naming; associated data, and transport methods needed to increase efficiencies and minimise costs. The harmonisation of required data and exchange practices reduces the individual mapping from multiple sources to a single process, thus avoiding errors. The image naming utilising a global standardised convention allows for a higher level of security against inadvertent over-writing.
This document is designed to be used by both manufacturers and end users; as well as set a framework for any third party providers that may service either trade partner.
2 Pharmaceutical images
The requirements outlined in this section are for:
Pharmaceutical images: Medication; solid form.
Practical application of these images include, but are not limited to:
■ Order Assembly
■ Robotic anti-counterfeiting
■ Visual validation
■ Emergency response
■ Reverse identification
■ Product selection verification via physical attribute
2.1 File naming
2.2 Image specifications
3 Required images
This section outlines the format of the pharmaceutical and the suggested image facings Front (in order of importance):
■ Largest surface area;
■ Company logo or brand;
■ Alpha characters (first character alphabetic order)
■ Numeric characters
Directly opposite the front
Another side (other than the front or back) which contains markings
3.3 Transdermal patches
3.4 Oral/Buccal strip
Contributors & Change Log
Log of Changes
Date of Change
Summary of Change
D.Clark / D.Buckley
Initial publication based on WR 16-483 and as reviewed by GS1 Healthcare Leadership team and GMD Product Image Specification subteam.